World’s first artificial pancreas app licensed for people with type 1 diabetes in UK

Cambridge University has launched the world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes , based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. The CamAPS FX app works with an insulin pump and a glucose monitor to automatically deliver insulin to people living with the condition via a complex algorithm.

Inflammation in the brain linked to several forms of dementia

The new study of the University of Cambridge suggests that inflammation is usually the body’s response to injury and stress – such as the redness and swelling that accompanies an injury or infection. However, inflammation in the brain – known as neuroinflammation – has been recognised and linked to many disorders including depression, psychosis and multiple sclerosis. It has also recently been linked to the risk of Alzheimer’s disease.

Researchers shed new light on how malaria parasites evade mosquitos’ defences

The malaria parasite uses a specific molecule on its surface to get around a mosquito’s immune system, allowing it to invade and infect humans.The molecule could be targeted by new transmission-blocking vaccines, or even thwarted by genetically modified mosquitos. The study, published in Proceedings of the National Academy of Sciences, was led by scientists at Imperial College London.